• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Acutaas Chemicals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 73056.0
  • ISIN : INE00FF01025
1,296.50 -31 (-2.33%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    1,288.20

  • Today’s High

    1,378.30

  • Open

    1,351.90

  • Perv Close

    1,327.40

  • 52W Low

    607.50

  • 52W High

    1,378.30

Key Indicators

  • P/E(TTM)

    55.76

  • Mar.Cap (₹Cr.)

    10,614.31

  • Div & Yield %

    0.12

  • Book Value(₹)

    160.21

  • Debt-Equity Ratio

    -2.33

  • AGM Date

    01-Aug-2025

  • EPS

    23.27

  • P/E Ratio

    55.76

Financials Ratios

  • Debt-Equity Ratio

    0.17

  • Mar.Cap (₹Cr.)

    10,614.31

  • RONW (%)

    10.67

  • ROCE (%)

    16.07

Score Board

  • Equity (₹ in Cr.)

    40.93

  • BV (₹)

    160.20

  • Sales( ₹ in Cr.)

    989.83

  • NP (in Cr.)

    159.55

  • NP Var(%)

    170.0

  • Div%

    30.0

  • CPS (₹)

    22.40

  • EPS (₹)

    19.50

  • Traded Value (₹ in Lakhs)

    10,623.31

  • 52 Week High

    1,378.30

  • 52 Week Low

    607.50

  • Price BSE

    1298.0

  • Price NSE

    1,297.00

  • Market Capital( in Cr.)

    10,623.31

  • P/C Ratio

    57.90

  • P/E Ratio

    66.60

  • Price Vs.BV

    19.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 687.58 616.73 520.14 340.61 239.64 235.59
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 687.58 616.73 520.14 340.61 239.64 235.59
Other Income 13.79 4.32 2.76 1.33 2.77 1.15
Stock Adjustments 26.94 14.96 9.50 -4.81 8.99 3.62
Total Income 728.31 636.01 532.40 337.13 251.40 240.36
EXPENDITURE :            
Raw Materials 434.96 345.85 282.33 174.87 137.90 152.58
Power and Fuel Cost 25.69 22.28 21.40 5.26 4.53 4.14
Employee Cost 60.92 48.84 41.37 20.99 12.77 11.43
Other Manufacturing Expenses 46.19 46.71 49.53 40.65 34.60 4.78
Selling and Administration Expenses 31.80 36.56 27.22 11.47 15.37 7.03
Miscellaneous Expenses 39.05 8.78 2.61 2.35 2.36 16.45
Employee Benefit Expenses 60.92 48.84 41.37 20.99 12.77 11.43
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 638.61 509.03 424.45 255.59 207.55 196.40
Operating Profit 89.69 126.98 107.94 81.53 43.86 43.96
Interest 5.89 2.41 6.41 5.62 5.59 4.75
Gross Profit 83.80 124.57 101.53 75.91 38.27 39.21
Depreciation 14.69 12.34 10.08 4.19 3.52 2.60
Profit Before Tax 69.11 112.23 91.45 71.72 34.75 36.61
Current Tax 20.91 26.38 16.72 17.56 6.80 8.98
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.51 2.50 2.78 0.16 0.49 3.00
Reported Net Profit 43.68 83.34 71.95 54.00 27.47 24.63
Extraordinary Items -15.35 -0.55 -0.10 -0.61 -0.69 0.00
Adjusted Net Profit 59.03 83.89 72.05 54.61 28.16 24.63
Adjustment below Net Profit -0.09 0.17 0.00 -21.03 -0.63 -10.52
P & L Balance brought forward 275.58 203.00 131.28 97.48 70.64 56.50
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 10.93 10.93 0.00 0.00 0.00 0.00
P & L Balance carried down 308.24 275.58 203.23 130.45 97.48 70.61
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 30.00 30.00 30.00 0.00 0.00 0.00
Dividend Per Share(Rs) 3.00 3.00 3.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 11.84 22.87 19.75 17.14 26.16 23.46
Earnings Per Share(Adj)-Unit Curr 5.92 11.44 9.88 - - -
Book Value 183.05 161.04 142.16 52.05 102.84 77.25
Book Value(Adj)-Unit Curr 91.53 80.52 71.08 - - -

Shareholding Pattern

  • Promoter Group

    32.66%

  • Public Share Holding

    67.34%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 26,741,416 32.66 26,741,416 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 26,741,416 32.66 26,741,416 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,947 0.01 8,947 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 13,866,847 16.94 13,866,847 117
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 3,832,028 4.68 3,832,028 3
Mutual Funds / UTI 13,322,393 16.27 13,322,393 20
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,167,560 1.43 1,167,560 20
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 32,197,775 39.33 32,197,775 161
2] Non Institution
Bodies Corporate 1,327,017 1.62 1,327,017 607
Clearing Members 58 0.00 58 2
Directors of their Relatives 663,200 0.81 663,200 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,130,646 1.38 1,130,646 3,422
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 591,089 0.72 591,089 2,314
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,332,683 8.96 7,332,683 21
Individuals holding nominal share capital up to Rs. 1 lakh 11,716,441 14.31 11,716,441 113,243
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 13,822 0.02 13,822 10
Others 2,500 0.00 2,500 2
Sub Total 22,929,731 28.01 22,929,731 119,726
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 81,868,922 100.00 81,868,922 119,890

Company Background

Acutaas Chemicals LtdPharmaceuticals - Indian - Bulk Drugs

  • Acutaas Chemicals Ltd
  • BSE Code : 73056.0
  • ISIN : INE00FF01025

  • Incorporation Year

    2007

  • Registered Office

    Plot No 440/4 5&6
    Road No 82/A GIDC Sachin, Surat,
    Gujarat-394230

  • Telephone

    91-261-2397193/91-7227977744

  • FAX

    91-261-2398436

  • Chairman

    Nareshbhai Ramjibhai Patel

  • Managing Director

    Nareshbhai Ramjibhai Patel

  • Company Secretary

    Ekta Kumari Srivastava

  • Auditor

    Maheshwari & Co

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Acutaas Chemicals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Acutaas Chemical 1,297.60 701.37 687.58 55.76 13.51
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10